Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use Dirnagl U; Becker K; Meisel ALancet Neurol 2009[Apr]; 8 (4): 398-412Neuroprotection and brain repair in patients after acute brain damage are still major unfulfilled medical needs. Pharmacological treatments are either ineffective or confounded by adverse effects. Consequently, endogenous mechanisms by which the brain protects itself against noxious stimuli and recovers from damage are being studied. Research on preconditioning, also known as induced tolerance, over the past decade has resulted in various promising strategies for the treatment of patients with acute brain injury. Several of these strategies are being tested in randomised clinical trials. Additionally, research into preconditioning has led to the idea of prophylactically inducing protection in patients such as those undergoing brain surgery and those with transient ischaemic attack or subarachnoid haemorrhage who are at high risk of brain injury in the near future. In this Review, we focus on the clinical issues relating to preconditioning and tolerance in the brain; specifically, we discuss the clinical situations that might benefit from such procedures. We also discuss whether preconditioning and tolerance occur naturally in the brain and assess the most promising candidate strategies that are being investigated.|*Ischemic Preconditioning/methods[MESH]|Animals[MESH]|Brain Ischemia/immunology/prevention & control/*therapy[MESH]|Brain/blood supply/physiopathology[MESH]|Cerebrovascular Circulation/physiology[MESH]|Gene Expression[MESH]|Humans[MESH]|Hypoxia-Inducible Factor 1/metabolism[MESH]|Microcirculation/physiology[MESH]|Randomized Controlled Trials as Topic[MESH]|Stroke/immunology/therapy[MESH]|Treatment Outcome[MESH] |